Wnt pathway: a hallmark of drug discovery challenge.
暂无分享,去创建一个
[1] R. Nusse,et al. Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities , 2017, Cell.
[2] S. Manicassamy,et al. Modulation of Inflammatory Responses by Wnt/β-Catenin Signaling in Dendritic Cells: A Novel Immunotherapy Target for Autoimmunity and Cancer , 2016, Front. Immunol..
[3] K. Bhalla,et al. Design, Synthesis, and Biological Evaluation of a Series of Anthracene-9,10-dione Dioxime β-Catenin Pathway Inhibitors. , 2015, Journal of medicinal chemistry.
[4] K. Bhalla,et al. Pre-clinical efficacy of combined therapy with novel β-catenin antagonist BC2059 and histone deacetylase inhibitor against AML cells , 2014, Leukemia.
[5] R. Nusse,et al. An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control , 2014, Science.
[6] Michael Kahn,et al. Can we safely target the WNT pathway? , 2014, Nature Reviews Drug Discovery.
[7] W. Sellers,et al. Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974 , 2013, Proceedings of the National Academy of Sciences.
[8] S. Krauss,et al. Tankyrases as drug targets , 2013, The FEBS journal.
[9] T. Grossmann,et al. Direct targeting of β-catenin: Inhibition of protein-protein interactions for the inactivation of Wnt signaling. , 2013, Bioorganic & medicinal chemistry.
[10] C. Niehrs. The complex world of WNT receptor signalling , 2012, Nature Reviews Molecular Cell Biology.
[11] B. R. Bowman,et al. Inhibition of oncogenic Wnt signaling through direct targeting of β-catenin , 2012, Proceedings of the National Academy of Sciences.
[12] F. E. Bertrand,et al. Developmental pathways in colon cancer , 2012, Cell cycle.
[13] N. Lin,et al. Structure-based discovery of a novel inhibitor targeting the β-catenin/Tcf4 interaction. , 2012, Biochemistry.
[14] R. Dasgupta,et al. An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway , 2011, Proceedings of the National Academy of Sciences.
[15] C. Nguyên,et al. Inhibition of Wnt/β-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis , 2010, Proceedings of the National Academy of Sciences.
[16] J. Freese,et al. Wnt signaling in development and disease , 2010, Neurobiology of Disease.
[17] Xi He,et al. Wnt/beta-catenin signaling: components, mechanisms, and diseases. , 2009, Developmental cell.
[18] Jie J. Zheng,et al. Discovery and Characterization of a Small Molecule Inhibitor of the PDZ Domain of Dishevelled* , 2009, The Journal of Biological Chemistry.
[19] Frank Petersen,et al. Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex , 2004 .
[20] Jonas Wittwer,et al. Differential role of p300 and CBP acetyltransferase during myogenesis: p300 acts upstream of MyoD and Myf5 , 2003, The EMBO journal.